Positive correlation between the dysregulation of transforming growth factor-β1 and aneurysmal pathological changes in patients with marfan syndrome

Circulation Journal

Volumn 77, Issue 4, 2013, Pages 952-958

  Kim, Koung Li ^a,c   Yang, Jeong Hoon ^a   Song, Sun Hwa ^c,d   Kim, Ji Yeon ^c,d   Jang, Shin Yi ^a   Kim, Jeong Min ^a   Kim, Jee Ah ^e   Sung, Ki Ick ^a   Kim, Young Wook ^a   Suh, Yeon Lim ^b   Suh, Wonhee ^c,d   Kim, Duk Kyung ^a  

^a Sungkyunkwan University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Ajou University   (South Korea)

^e Konkuk University   (South Korea)

Author keywords

Correlation analysis; Marfan syndrome; Transforming growth factor

Indexed keywords

SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AORTA ANEURYSM; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MARFAN SYNDROME; NICK END LABELING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TISSUE DEGENERATION; WESTERN BLOTTING;

ADULT; AORTA; AORTIC ANEURYSM; APOPTOSIS; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MARFAN SYNDROME; PHOSPHORYLATION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84875490676     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0874     Document Type: Article

References (12)

1. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352: 337-339.
2. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003; 33: 407-411.
3. Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, Bedja D, et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004; 114: 1586-1592.
4. Kim SK, Park JH, Kim JY, Choi JI, Joung B, Lee MH, et al. High plasma concentrations of transforming growth factor-beta and tissue inhibitor of metalloproteinase-1: Potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation. Circ J 2011; 75: 557-564.
5. Gomez D, Al Haj Zen A, Borges LF, Philippe M, Gutierrez PS, Jondeau G, et al. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol 2009; 218: 131-142.
6. Matt P, Schoenhoff F, Habashi J, Holm T, Van Erp C, Loch D, et al. Circulating transforming growth factor-beta in Marfan syndrome. Circulation 2009; 120: 526-532.
7. Nataatmadja M, West J, West M. Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation 2006; 114: I371-I377.
8. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312: 117-121.
9. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47: 476-485.
10. Oklu R, Hesketh R, Wicky S, Metcalfe JC. Localization of latent transforming growth factor-β binding protein-1 in human coronary atherosclerotic plaques. Circ J 2011; 75: 196-200.
11. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989; 64: 507-512.
12. Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, et al. Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 2011; 332: 358-361.